Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis

[1]  Robert E. Lewis,et al.  Essential Role for Dnmt1 in the Prevention and Maintenance of MYC-Induced T-Cell Lymphomas , 2013, Molecular and Cellular Biology.

[2]  M. L. Le Beau,et al.  Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. , 2013, Blood.

[3]  N. Yoo,et al.  Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[4]  Alfonso Valencia,et al.  Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.

[5]  Michael A. Freitas,et al.  Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL) , 2012, Proceedings of the National Academy of Sciences.

[6]  W. C. Chan,et al.  Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. , 2012, The Journal of clinical investigation.

[7]  Joshua F. McMichael,et al.  Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.

[8]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[9]  Li Ding,et al.  Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes , 2011, Leukemia.

[10]  Irving L. Weissman,et al.  A comprehensive methylome map of lineage commitment from hematopoietic progenitors , 2010, Nature.

[11]  M. L. Le Beau,et al.  DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. , 2010, Cancer research.

[12]  S. Shurtleff,et al.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Jaenisch,et al.  Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  E. Li,et al.  Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting , 2004, Nature.

[15]  Saijuan Chen,et al.  DNA methyltransferases in hematologic malignancies. , 2013, Seminars in hematology.